| Trademark Snap Shot Publication Stylesheet (Table presents the data on Publication Approval) |
|||
OVERVIEW |
|||
| SERIAL NUMBER | 85476589 | FILING DATE | 11/18/2011 |
| REG NUMBER | 0000000 | REG DATE | N/A |
| REGISTER | PRINCIPAL | MARK TYPE | TRADEMARK |
| INTL REG # | N/A | INTL REG DATE | N/A |
| TM ATTORNEY | MACIOL, GENE V J |
L.O. ASSIGNED | 103 |
PUB INFORMATION |
|||
| RUN DATE | 02/14/2013 | ||
| PUB DATE | N/A | ||
| STATUS | 680-APPROVED FOR PUBLICATION | ||
| STATUS DATE | 02/13/2013 | ||
| LITERAL MARK ELEMENT | AFIGILE | ||
| DATE ABANDONED | N/A | DATE CANCELLED | N/A |
| SECTION 2F | NO | SECTION 2F IN PART | NO |
| SECTION 8 | NO | SECTION 8 IN PART | NO |
| SECTION 15 | NO | REPUB 12C | N/A |
| RENEWAL FILED | NO | RENEWAL DATE | N/A |
| DATE AMEND REG | N/A | ||
FILING BASIS |
|||||
| FILED BASIS | CURRENT BASIS | AMENDED BASIS | |||
| 1 (a) | NO | 1 (a) | NO | 1 (a) | NO |
| 1 (b) | YES | 1 (b) | YES | 1 (b) | NO |
| 44D | NO | 44D | NO | 44D | NO |
| 44E | NO | 44E | NO | 44E | NO |
| 66A | NO | 66A | NO | ||
| NO BASIS | NO | NO BASIS | NO | ||
MARK DATA |
|
| STANDARD CHARACTER MARK | YES |
| LITERAL MARK ELEMENT | AFIGILE |
| MARK DRAWING CODE | 4-STANDARD CHARACTER MARK |
| COLOR DRAWING FLAG | NO |
CURRENT OWNER INFORMATION |
|
| PARTY TYPE | 10-ORIGINAL APPLICANT |
| NAME | Eli Lilly and Company |
| ADDRESS | Lilly Corporate Center Indianapolis, IN 46285 |
| ENTITY | 03-CORPORATION |
| CITIZENSHIP | Indiana |
GOODS AND SERVICES |
|
| INTERNATIONAL CLASS | 005 |
| DESCRIPTION TEXT | Pharmaceutical preparations, namely, pharmaceutical preparations for the diagnosis and treatment of alcohol use disorders, Alzheimer's, anxiety disorders, atherosclerosis, autoimmune diseases and disorders, blood disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cholesterol disorders, cystic fibrosis, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, obesity, pain, pancreatic diseases and disorders, psychiatric disorders, reproductive system diseases and disorders, sleep disorders, urological disorders; antipsychotic pharmaceutical preparations; antidepressants; Veterinary preparations, namely, vaccines, oral and injectable antimicrobial preparations for the treatment and control of infectious diseases in food producing animals and livestock, immunorestorative biopharmaceuticals, and other medicinal drugs for the prevention and treatment of viral, infectious, and metabolic diseases in animals; medicated animal feed and water additives in the nature of dietary supplements for production enhancement for livestock; veterinary preparations for controlling and destroying vermin, namely, ectoparasiticides, insecticides and parasiticides; Veterinary hormone preparations and hormone preparation implants for animals, namely, progesterone, estrogen and testosterone; Veterinary preparations for food safety, food animal processing and food animal processing aids, namely, bacteriophage, antimicrobials and vaccines to reduce levels of food borne pathogens carried in or on livestock, poultry or meat and to inhibit microbial decomposition in food and animal feed; veterinary preparations, namely, medical diagnostic agents, tests, and preparations and substances to identify pathogens and residues of biological interest for veterinary use; Veterinary preparations for companion animals, namely to treat parasitic infections, diabetes, endocrine disorders, obesity, blood disorders, dental and oral diseases, pain, inflammation, gastrointestinal disorders, central nervous system disorders, neurological and neurodegenerative disorders, cardiovascular conditions, dermatologic conditions, urogenital and urinary conditions, osteoarthritis, otitis, wound healing, infections, allergy atopic conditions, liver diseases and disorders and nonsurgical sterilization, namely, hormones for the control/prevention of reproductive functions; veterinary preparations for treating and preventing fleas on companion animals; veterinary preparations, namely vaccines for companion animals |
GOODS AND SERVICES CLASSIFICATION |
|||||||
| INTERNATIONAL CLASS | 005 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
MISCELLANEOUS INFORMATION/STATEMENTS |
|
| CHANGE IN REGISTRATION | NO |
PROSECUTION HISTORY |
||||
| DATE | ENT CD | ENT TYPE | DESCRIPTION | ENT NUM |
| 02/13/2013 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | 016 |
| 02/08/2013 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | 015 |
| 02/08/2013 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | 014 |
| 02/08/2013 | ERFR | I | TEAS REQUEST FOR RECONSIDERATION RECEIVED | 013 |
| 09/19/2012 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | 012 |
| 09/19/2012 | GNFR | O | FINAL REFUSAL E-MAILED | 011 |
| 09/19/2012 | CNFR | R | FINAL REFUSAL WRITTEN | 010 |
| 08/31/2012 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | 009 |
| 08/31/2012 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | 008 |
| 08/31/2012 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | 007 |
| 03/15/2012 | GPRN | O | NOTIFICATION OF PRIORITY ACTION E-MAILED | 006 |
| 03/15/2012 | GPRA | F | PRIORITY ACTION E-MAILED | 005 |
| 03/15/2012 | CPRA | R | PRIORITY ACTION WRITTEN | 004 |
| 03/06/2012 | DOCK | D | ASSIGNED TO EXAMINER | 003 |
| 11/28/2011 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 002 |
| 11/22/2011 | NWAP | I | NEW APPLICATION ENTERED IN TRAM | 001 |
CURRENT CORRESPONDENCE INFORMATION |
|
| ATTORNEY | Robert E. Lee, Jr. |
| CORRESPONDENCE ADDRESS | ROBERT E. LEE, JR. ELI LILLY AND COMPANY LILLY CORPORATE CENTER INDIANAPOLIS, IN 46285-0001 |
| DOMESTIC REPRESENTATIVE | NONE |